COMMUNIQUÉS West-GlobeNewswire

Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2017 Financial Results, Provide Corporate Update, Host Conference Call
15/02/2018
MENLO PARK, Calif., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT ) today announced it will report its 2017 financial results and provide a corporate update on February 22, 2018. The [...]
Dova Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Operating and Financial Results
15/02/2018
DURHAM, N.C., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA ), a pharmaceutical company focused on acquiring, developing, and commercializing drug candidates for rare diseases where there is [...]
Affimed Announces Closing of Public Offering of Common Stock and Exercise of Underwriters' Option to Purchase Additional Shares
15/02/2018
Heidelberg, Germany, February 15, 2018 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, today announced the closing [...]
Allscripts announces fourth quarter and 2017 full-year results
15/02/2018
Fourth quarter GAAP revenue $517 million, $547 million non-GAAP, representing growth of 22 and 27 percent, respectively, year-over-year Fourth quarter GAAP EPS of $0.03; non-GAAP EPS of $0.18, up 29% Y/Y, the highest [...]
Allscripts to sell OneContent business to Hyland
15/02/2018
CHICAGO, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX ) has signed a definitive agreement to sell its OneContent business to Hyland Software, Inc., a leading provider of content services solutions to the [...]
Cytokinetics, Inc. Reports Fourth Quarter 2017 Financial Results
15/02/2018
Company Provides 2018 Financial Guidance and Expected Milestones; Reduced Operating Expenses vs. 2017; Over Two Years of Cash Based on Current Burn Rate CK-2127107 Advancing in Four Clinical Trials Under Collaboration [...]
Burgess Source Achieves HITRUST CSF® Certification to Further Mitigate Risk in Third Party Privacy, Security and Compliance
15/02/2018
ALEXANDRIA, Va., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Burgess, an innovator in healthcare payment operations for over 20 years, today announced that Burgess Group's Source Application has earned Certified status for [...]
Inovalon to Participate at 2018 RBC Capital Markets Global Healthcare Conference
15/02/2018
BOWIE, Md., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV ), a leading technology company providing advanced, cloud-based platforms empowering a data-driven transformation from volume-based to value-based [...]
LHC Group Announces Fourth Quarter and Year-End 2017 Earnings Release and Conference Call Dates
15/02/2018
LAFAYETTE, La., Feb. 15, 2018 (GLOBE NEWSWIRE) -- LHC Group, Inc . (NASDAQ: LHCG ) today announced details for the release of its results for the fourth quarter and year ended December 31, 2017. LHC Group plans to issue [...]
FDA Accepts New Drug Application and Grants Priority Review for Ivosidenib in Relapsed or Refractory AML with an IDH1 Mutation
15/02/2018
– PDUFA date set for August 21, 2018 – CAMBRIDGE, Mass., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO ), a leader in the field of cellular metabolism to treat cancer and rare genetic [...]
Diaxonhit : Distribution exclusive de la plateforme de biologie moléculaire VERIGENE®
15/02/2018
Distribution exclusive de la plateforme de biologie moléculaire VERIGENE® Diaxonhit devient, par l'intermédiaire de sa filiale eurobio-ingen, le distributeur exclusif de la gamme de biologie moléculaire VERIGENE® de la [...]
GUERBET : 2017 revenue at constant exchange rates: €812.4 million; +4.7%
15/02/2018
Villepinte, February 15, 2018 - Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, is reporting revenue of €807.1 million at December 31, 2017, up by 4.0% at current [...]
GUERBET : Chiffre d'affaires 2017 à taux de change constant : 812,4 M€ ; +4,7%
15/02/2018
Villepinte, le 15 février 2018 - Guerbet (FR0000032526 GBT), spécialiste mondial des produits de contraste et solutions pour l'imagerie médicale, publie un chiffre d'affaires de 807,1 M€ au 31 décembre 2017, en [...]
Catalyst Biosciences Announces Closing of Public Offering of Common Stock
15/02/2018
SOUTH SAN FRANCISCO, Calif., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO ), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology [...]
PetVivo Holdings, Inc. Adds Special Revenue Consultant Approaching Commercial Production
15/02/2018
MINNEAPOLIS, Feb. 15, 2018 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. ( www.petvivo.com ) (OTCMARKET:PETV) an emerging biomedical device Company, is moving Mr. David Merrill, a member of the Board of Directors, to cover [...]
JAMA Oncology Publication Demonstrates EndoPredict® (EPClin) Significantly Outperforms Oncotype DX® Recurrence Score in Early-Stage Breast Cancer
15/02/2018
SALT LAKE CITY, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN ) today announced that a comparative analysis of commercially available prognostic breast cancer tests in patients with early-stage [...]
Daré Bioscience, Inc. Announces Effective License and Collaboration Agreement for Topical Sildenafil for Female Sexual Arousal Disorder
15/02/2018
SAN DIEGO, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE ), a clinical-stage, women’s biopharmaceutical company, today announced that it has met the funding requirement for obtaining an exclusive [...]
Sales of Olainfarm in January Exceed 9 Million Euros
15/02/2018
Olaine, 2018-02-15 17:03 CET (GLOBE NEWSWIRE) -- January 2018, consolidated sales Sales, Thsnd. EUR Changes to January 2017 Share in total sales Latvia 2 922 18% 32% Russia 1 716 -27% 19% Belarus 1 696 5% 18% Ukraine 1 [...]
Kura Oncology Provides Update on Phase 2 Trial of Tipifarnib in HRAS Mutant Head and Neck Cancer
15/02/2018
– Confirmed partial responses observed in five of six evaluable patients with HRAS mutant HNSCC – – Rate of enrollment increasing with three additional patients enrolled in four months – – Initiation of registrational [...]

Pages